Comparing higher and standard doses of zinc for very preterm infants
Official title: Higher and Standard Doses of Enteral Zinc Supplementation in Very Preterm Infants: A Randomized Controlled Trial
Run by Prince of Songkla University · NCT06219525 · Data updated 2026-11-12
This study tests if giving very preterm infants a higher dose of zinc can help them grow better and develop more normally compared to a standard dose.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Prince of Songkla University Academic / other |
| Locations | 1 site (Hat Yai, Changwat Songkhla) |
| Status | Recruiting |
| Started | April 2, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2027 |
| Registry record updated | September 19, 2024 |
| Trial ID | NCT06219525 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are very preterm neonates born between 24 and 32 weeks of gestation with a body weight less than 800 grams.
✕Probably not a fit
Patients who may not benefit from this study include those with congenital infections, severe birth asphyxia, or other significant health complications.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effects of higher (10 mg/day) versus standard (1 mg/day) doses of zinc supplementation in very preterm infants with a birth weight of less than 1800 grams. The study involves random allocation of neonates to receive either dose, with the administration of zinc occurring once daily after feeding. The primary outcomes include growth velocities and neurodevelopmental assessments at 24 months postnatal age. The trial is conducted in a blinded manner to ensure unbiased results.
Why it matters
Potential benefit: If successful, this study could improve growth and neurodevelopment outcomes in very preterm infants suffering from zinc deficiency.
How similar studies have gone: Other studies have shown promising results with zinc supplementation in preterm infants, indicating potential benefits in growth and development.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Very preterm neonates (gestational age \[GA\]: 24 0/7-32 6/7 weeks and BW: 401-1800 grams) were consecutively admitted in the NICU and NMCU * Body weight at enrollment less than 800 grams * Stable neonates and full enteral feeding (150 mL/kg/day) at least for a few days Exclusion Criteria: * Outborn neonate who was admitted in study center after 7 days of life * Congenital infections * Malformations, syndromes, or genetic defects * Evidence of culture proven sepsis or necrotizing enterocolitis or death diagnosed before enrollment * Gastrointestinal (GI) surgery or high GI fluid output (usually ileostomy losses) * Unstable neonate during weighing including on intercostal drainage tube or drainage * Neonates need diuretics more than 7 days * Severe birth asphyxia (5-minute Apgar score less than 4) * Parents' decision not to participate the study
Where it's running
-
Songklanagarind Hospital, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand Recruiting
Study contacts
- Principal investigator: Anucha Thatrimontrichai, MD — Prince of Songkla University
- Study coordinator: Anucha Thatrimontrichai, MD
- Email: tanucha@medicine.psu.ac.th
- Phone: +66 954300690
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Daily beef intake's impact on zinc absorption and heart health
This study is testing if eating beef every day can help people aged 55 to 70 absorb more zinc and improve their heart health compared to other protein sources.
-
Giving protective particles from donor breast milk to very premature babies
This pilot will try giving extracellular vesicles from donor human milk to babies born before 32 weeks to see if it helps feeding and protects their intestines.
-
Treatment for specific types of pediatric and young adult leukemia using engineered T cells
This study is testing a special type of T cell therapy to see if it can help young patients with certain high-risk forms of leukemia feel better.
-
Optimising anakinra dose and route for very premature infants
This trial will test different doses and ways of giving the drug anakinra to very premature infants to find the safest dosing that reaches target blood levels.
-
Personalized nutrition to support growth and brain development in preterm infants
This study is testing whether a personalized nutrition plan for very preterm infants can help them grow better and develop their brains more effectively compared to standard milk fortification.
-
Quality improvement and research for high-risk newborns in Switzerland
This study is trying to improve the care and safety of high-risk newborns in Switzerland by collecting and sharing information from different hospitals to help doctors do a better job.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.